In the space of about ten days, US lawmakers introduced a small mountain of artificial-intelligence legislation. The bills, rounded up by Nextgov/FCW, pull in two opposite directions at once. One set treats AI as a tool the government should be deployi…
The convergence of advanced skincare science and consumer electronics is rewriting the rules of personal care. For decades, individuals relied entirely on the passive application of topical formulas, smoothing a cream over the skin surface and hoping t…
Two robots that look roughly like people just reached inside a live animal and removed an organ. No film studio staged the scene. It happened in a lab in California, and it is a first for medicine. Surgeons at the University of California San Diego use…
Auxilium Biotechnologies has bioprinted kidney and liver tissue aboard the International Space Station. It says that is the first time anyone has made either in space. The samples flew home last month on a SpaceX cargo capsule, and the company announce…
Cambridge biotech Alchemab Therapeutics has extended its Series A round with a £25 million ($34 million) investment from the British Business Bank, which the company says is the state-owned lender’s largest backing of a life sciences company to date. T…
ResMed has agreed to sell MatrixCare, its home-health and senior-care software business, to the private equity firm Frazier Healthcare Partners for $490m in cash. The deal lets the medical-device maker part with a unit it had owned for years to focus o…
Utah has quietly become the first US state to let an AI chatbot renew prescriptions without a doctor, according to the Associated Press. The programme, run by a company called Doctronic, launched in January and has set off a fierce medical debate. Resi…
Your prescription, printed to order. A Finnish startup wants to turn the back room of your pharmacy into a tiny, automated drug factory, and it just raised $14m to do it in America. CurifyLabs has closed a $14m (€12m) Series A, the company announced. T…
Novartis has agreed to buy Myricx Bio, a small British oncology company, for up to $1.5bn, adding an early-stage but potentially significant technology to a cancer pipeline the industry keeps racing to expand. The Swiss group will pay $1.1bn upfront, w…
The NHS will use AI inside its app to direct patients in England to the right services, the government has announced. The tool will assess symptoms and work out whether someone needs a GP appointment, a pharmacy visit, or a trip to A&E. The update …